MicroRNAs and cancer


MicroRNAs are a type of small non-coding RNA molecule that performs a vital role in post-transcriptional gene regulation. Since miRNAs were first identified in 1993, a number of studies have demonstrated that they act as tumor suppressors or oncogenes in human cancer, including colorectal, lung, brain, breast and liver cancer, and leukemia. Studies have previously revealed that miRNA profiling is important for the diagnosis and prognosis of patients with cancer, while certain miRNAs possess the potential to be used as diagnostic and prognostic biomarkers or therapeutic targets in cancer. Studies review and examines the roles of miRNAs in prognosis, cancer diagnosis and treatment, discusses the probable therapeutic modality of misusing miRNAs



 


    Related Conference of MicroRNAs and cancer

    April 16-17, 2025

    9th International Conference on Internal Medicine

    Berlin, Germany
    May 12-13, 2025

    19th International Conference on Obesity Medicine

    Toronto, Canada
    June 24-25, 2025

    3rd Global Summit on HIV-AIDS and STDs

    Chicago, USA
    July 21-22, 2025

    11th World Congress on Anesthesia and Critical Care

    Aix-en-Provence, France
    July 21-22, 2025

    24th International Conference on Genomics and Molecular Biology

    Aix-en-Provence, France
    August 07-08, 2025

    12th World Summit on Epilepsy and Bipolar Disorders

    Paris, France
    August 25-26, 2025

    8th International Conference on Community Nursing and Public Health

    Singapore City, Singapore
    September 22-23, 2025

    39th International Conference on Cancer Science & Therapy

    Amsterdam, Netherlands
    October 16-17, 2025

    19th International Conference on Pathology and Laboratory Medicine

    Aix-en-Provence, France
    November 03-04, 2025

    5th World Medicine Congress

    Rome, Italy

    MicroRNAs and cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in